PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
229.02 - 234.51
169.21 - 260.10
55.82M / 54.92M (Avg.)
32.24 | 7.26
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
74.01%
Net income growth at 50-75% of VUZI's 126.54%. Martin Whitman would worry about lagging competitiveness unless expansions are planned.
20.25%
D&A growth well above VUZI's 6.88%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
190.60%
Some yoy growth while VUZI is negative at -168.64%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
22.70%
SBC growth well above VUZI's 0.01%. Michael Burry would flag major dilution risk vs. competitor’s approach.
283.07%
Well above VUZI's 81.83% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
74.24%
AR growth is negative or stable vs. VUZI's 153.08%, indicating tighter credit discipline. David Dodd would confirm it doesn't hamper sales volume.
-434.33%
Negative yoy inventory while VUZI is 73.39%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
15.69%
A yoy AP increase while VUZI is negative at -220.10%. John Neff would see competitor possibly improving relationships or liquidity more rapidly.
2387.27%
Growth well above VUZI's 113.06%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
No Data
No Data available this quarter, please select a different quarter.
128.81%
Operating cash flow growth above 1.5x VUZI's 52.02%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
11.36%
Some CapEx rise while VUZI is negative at -8.51%. John Neff would see competitor possibly building capacity while we hold back expansions.
-890.57%
Negative yoy acquisition while VUZI stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
-87.53%
Negative yoy purchasing while VUZI stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
24.72%
Liquidation growth of 24.72% while VUZI is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
-82.14%
Both yoy lines negative, with VUZI at -6.40%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-2571.85%
Both yoy lines negative, with VUZI at -8.51%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
-31.28%
Both yoy lines negative, with VUZI at -100.00%. Martin Whitman suspects an environment or preference for internal financing over new equity in the niche.
-2.42%
We cut yoy buybacks while VUZI is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.